We are focused on bringing innovation to the treatment of cachexia and other muscle wasting conditions with a vision to transform care for an under-served and vulnerable patient population, prolong and improve the quality of their lives, restore their dignity and ease the burden for the patient, carer and provider.
NEWS
Apr 24, 2025
Actimed Therapeutics Appoints Shaun Claydon as Chief Financial Officer
Feb 6, 2025
Actimed Therapeutics Expands Intellectual Property Portfolio